Exploration Of 4( <i>1H</i> )-Pyridones As A Novel Family Of Potent Antimalarial Inhibitors Of The Plasmodial Cytochrome bc1
José M. Bueno(GlaxoSmithKline (United Kingdom)), Geo Derimanov(South College), Íñigo Angulo‐Barturen(Euskadiko Parke Teknologikoa), José M. Fiandor(GlaxoSmithKline (United Kingdom)), Domingo Gargallo‐Viola(GlaxoSmithKline (United Kingdom)), Francisco‐Javier Gamo(GlaxoSmithKline (France)), Santiago Ferrer(GlaxoSmithKline (Spain)), Esperanza Herreros(GlaxoSmithKline (Spain))
Cited by 63
Related Papers
Improved Murine Model of Malaria Using<i>Plasmodium falciparum</i>Competent Strains and Non-Myelodepleted NOD-<i>scid IL2R</i>γ<sup><i>null</i></sup>Mice Engrafted with Human Erythrocytes
|Antimicrobial Agents and Chemotherapy|2009|189
A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes
|PLoS ONE|2008|164
Synthesis and Structure–Activity Relationships of 4-Pyridones as Potential Antimalarials
|Journal of Medicinal Chemistry|2008|139
Transmission of Pneumocystis carinii Disease from Immunocompetent Contacts of Infected Hosts to Susceptible Hosts
|European Journal of Clinical Microbiology & Infectious Diseases|2000|134